These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Psychotropic medications and cytochrome P450 2D6: pharmacokinetic considerations in the elderly. Shulman RW; Ozdemir V Can J Psychiatry; 1997 Jun; 42 Suppl 1():4S-9S. PubMed ID: 9220124 [TBL] [Abstract][Full Text] [Related]
3. Cytochromes and psychotropic drug interactions. Bates GD; Van Woerkom AE Br J Psychiatry; 1996 Nov; 169(5):670. PubMed ID: 8932910 [No Abstract] [Full Text] [Related]
4. Current applications of clinical genetic testing for psychiatric practice. Mrazek DA Minn Med; 2007 Jan; 90(1):42-3. PubMed ID: 17305105 [TBL] [Abstract][Full Text] [Related]
5. [Clinical significance of pharmacogenetics in psychiatry]. Skrętkowicz J; Barańska M; Rychlik-Sych M Wiad Lek; 2013; 66(2 Pt 2):185-91. PubMed ID: 25775815 [TBL] [Abstract][Full Text] [Related]
6. Developmental pharmacology. van den Anker JN Dev Disabil Res Rev; 2010; 16(3):233-8. PubMed ID: 20981761 [TBL] [Abstract][Full Text] [Related]
7. [Psychopharmacotherapy of the elderly]. Wollmer MA; Müller-Spahn F Ther Umsch; 2009 Jun; 66(6):459-65. PubMed ID: 19496042 [TBL] [Abstract][Full Text] [Related]
8. [Therapeutic drug monitoring: A pharmacotherapeutic tool in psychiatry]. Stephan PL; Etzensberger M; Jaquenoud Sirot E Praxis (Bern 1994); 2006 Apr; 95(17):671-8. PubMed ID: 16686323 [TBL] [Abstract][Full Text] [Related]
9. [Interactions between psychopharmaceuticals and other drugs]. Markus W MMW Fortschr Med; 2006 Nov; 148(46):31-5. PubMed ID: 17615785 [TBL] [Abstract][Full Text] [Related]
10. Cytochromes in psychopharmacology. von Moltke LL; Greenblatt DJ; Harmatz JS; Shader RI J Clin Psychopharmacol; 1994 Feb; 14(1):1-4. PubMed ID: 8150999 [No Abstract] [Full Text] [Related]
11. Relevance of pharmacokinetics to prescribing in psychiatry. Ashton H; Harrison R Br J Hosp Med; 1994 Jun 1-14; 51(11):573, 576-80. PubMed ID: 7952746 [TBL] [Abstract][Full Text] [Related]
12. Is pharmacogenetic CYP2D6 testing useful? Vetti HH; Molven A; Eliassen AK; Steen VM Tidsskr Nor Laegeforen; 2010 Nov; 130(22):2224-8. PubMed ID: 21109842 [TBL] [Abstract][Full Text] [Related]
13. Psychopharmacology in patients with hepatic and gastrointestinal disease. Leipzig RM Int J Psychiatry Med; 1990; 20(2):109-39. PubMed ID: 2203695 [TBL] [Abstract][Full Text] [Related]
14. Intermediate metabolizer: increased side effects in psychoactive drug therapy. The key to cost-effectiveness of pretreatment CYP2D6 screening? Laika B; Leucht S; Heres S; Steimer W Pharmacogenomics J; 2009 Dec; 9(6):395-403. PubMed ID: 19451914 [TBL] [Abstract][Full Text] [Related]
15. [Pharmacologic interactions of antibiotics and psychotropic drugs]. Joos AA Psychiatr Prax; 1998 Mar; 25(2):57-60. PubMed ID: 9577846 [TBL] [Abstract][Full Text] [Related]
16. [CYP2D6 gene polymorphism in psychiatric patients resistant to standard pharmacotherapy]. Zabrocka M; Woszczek G; Borowiec M; Rabe-Jabłońska J; Kowalski ML Psychiatr Pol; 1999; 33(1):91-100. PubMed ID: 10786218 [TBL] [Abstract][Full Text] [Related]
17. Seizure risk associated with psychotropic drugs: clinical and pharmacokinetic considerations. Alldredge BK Neurology; 1999; 53(5 Suppl 2):S68-75. PubMed ID: 10496236 [TBL] [Abstract][Full Text] [Related]